Basel Medical Group Ltd (NASDAQ:BMGL) Stock Short Interest Report for October

Basel Medical Group Ltd (NASDAQ:BMGL) saw a significant increase in short interest in the month of October. As of October 30th, there was short interest totaling 107,869 shares, an increase of 731.6% from the October 15th total of 12,972 shares. Currently, 6.8% of the company’s stock are short sold. Based on an average daily trading volume, of 1,433,048 shares, the short-interest ratio is currently 0.1 days.

Analysts Set New Price Targets

BMGL has been the subject of several recent research reports. Wall Street Zen raised Basel Medical Group to a “hold” rating in a research report on Saturday, November 7th. Weiss Ratings raised Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company currently has an average rating of “Sell”.

Basel Medical Group Stock Performance

Shares of BMGL stock traded down $0.13 during trading hours on Thursday, reaching $0.55. 1,273,891 shares of the company’s stock were exchanged, compared to its average volume of 418,897. The stock’s 50 day moving average is $4.21 and its 200-day moving average is $6.30. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.21 and a current ratio of 1.23. Basel Medical Group has a fifty-two week low of $0.51 and a fifty-two week high of $17.70.

Basel Medical Group (NASDAQ:BMGL) last posted its quarterly earnings data on Friday, October 30th. The company reported ($0.31) earnings per share for the quarter. The firm had revenue of $3.14 million during the quarter.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.